GAUDIUM IVF N WOMEN H L
GAUDIUMIVF · General/Diversified · NSE
₹103
Current Market Price
Fair Value (DCF)
₹49
Margin of Safety
-52.4%
Updated 35m ago
YieldIQ Score
47/100
Piotroski F-Score
5/9
Economic Moat
Wide
Confidence
39%
ROE
—
Debt/Equity
0.00
WACC
11.1%
Market Cap
₹751 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
53.1%
Return on capital employed
EV / EBITDA
—
Enterprise multiple
Debt / EBITDA
0.6×
Leverage vs earnings
Interest Coverage
19.3×
EBIT covers interest
Current Ratio
1.42×
Short-term liquidity
Asset Turnover
0.80×
Revenue per ₹ of assets
Revenue CAGR (3Y)
24.6%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹103.24
Bear case
₹26.38
MoS -291.4%
Base case
₹49.13
MoS -110.1%
Bull case
₹55.3
MoS -86.7%
Ratio Trends
GAUDIUMIVF · last 4 annual periods
ROE
41.3%
ROCE
43.1%
Operating Margin
—
Debt / Equity
0.45×
PE
—
EV / EBITDA
—
Historical Financials
GAUDIUMIVF · Annual, last 4 years· amounts in ₹Cr unless noted
| Metric | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | ₹36.5 Cr | ₹44.2 Cr | ₹47.9 Cr | ₹70.7 Cr | +24.6% |
| EBITDA | ₹13.4 Cr | ₹20.1 Cr | ₹19.5 Cr | ₹28.9 Cr | +29.1% |
| EBIT | — | — | — | — | — |
| PAT | ₹8.8 Cr | ₹13.5 Cr | ₹10.3 Cr | ₹19.1 Cr | +29.4% |
| EPS (diluted) | — | — | — | — | — |
| CFO | ₹-1.0 Cr | ₹23.9 Cr | ₹3.4 Cr | ₹8.7 Cr | — |
| CapEx | ₹-1.4 Cr | ₹-15.3 Cr | ₹-2.8 Cr | ₹-8.9 Cr | — |
| FCF | ₹-2.4 Cr | ₹8.6 Cr | ₹0.7 Cr | ₹-0.2 Cr | — |
| Total Assets | ₹17.8 Cr | ₹36.6 Cr | ₹51.0 Cr | ₹88.5 Cr | +70.8% |
| Total Debt | ₹5.9 Cr | ₹11.5 Cr | ₹17.4 Cr | ₹20.6 Cr | +51.3% |
| Shareholders' Equity | ₹9.3 Cr | ₹22.7 Cr | ₹27.0 Cr | ₹46.3 Cr | +70.8% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
GAUDIUMIVF vs 3 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| MAXIND MAXIND | — | — | Pending | -39.1% | — |
| GKSL GKSL | — | — | Pending | 37.0% | — |
| LOTUSEYE LOTUSEYE | — | — | Pending | 1.2% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for GAUDIUMIVF in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. GAUDIUM IVF N WOMEN H L (GAUDIUMIVF.NS) trades at 103.24 vs a model fair value of 49.13, a gap of -52.4%. Piotroski F-score: 5/9. Moat la...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of GAUDIUMIVF →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for GAUDIUMIVF →
Compare
Head-to-head with peers
Compare GAUDIUMIVF side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse GAUDIUMIVFNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.